BTG PLC | |
Stock Exchange | Other OTC |
EPS |
$0.06 |
Market Cap |
$4.06 B |
Shares Outstanding |
387.11 M |
Public Float |
- |
BTG PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
387.11 M |
Public Float |
- |
BTG PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP5.02 |
Market Cap |
GBP3.25 B |
Shares Outstanding |
387.11 M |
Public Float |
340.38 M |
Address |
5 Fleet Place London London & South East EC4M 7RD United Kingdom |
Employees | - |
Website | http://btgplc.com |
Updated | 07/08/2019 |
BTG Plc is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following business segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment provides therapies for cancer, sever emphysema, and vascular conditions such as severe blood clots and varicose veins. |